Receive our newsletter – data, insights and analysis delivered to you
  1. News
July 17, 2020

Topcon acquires Elektron Eye Technology’s Henson perimeter business

Japan-based Topcon Healthcare has acquired Henson line of perimeter business of UK-based Elektron Eye Technology (EET).

Japan-based Topcon Healthcare has acquired Henson line of perimeter business of UK-based Elektron Eye Technology (EET).

As part of the acquisition, a number of EET staff will transition to Topcon, while the product manufacturing operations will remain in the UK.

The Henson line of perimetry products is well regarded in the eye care industry for their accuracy, speed and ease of use.

The deal’s terms were not disclosed. It includes products such as Henson 9000 and 7000.

EET’s Henson 9000 is an optimal perimeter for the early detection of glaucoma and the ongoing monitoring of established loss.

The Henson 7000, which is designed to perform suprathreshold glaucoma screening in the central field, is an affordable, lightweight, mobile perimeter.

Content from our partners
The added value of Qarad’s multilingual freephone service to their eIFU solution
Small and simple: how medical device manufacturers select materials
Precision wire: The future of bespoke medical treatment

Topcon Healthcare Marketing and Product Design global VP John Trefethen said: “The acquisition of the Henson range of products will provide us with the opportunity to strategically develop this area of the company’s product portfolio.

“With Topcon’s growing emphasis on screening and early disease detection, the Henson product range perfectly complements our global strategy. I welcome the EET team members to the Topcon Healthcare Family.”

EET is a subsidiary of Elektron Technology and is known for fast-moving engineered product (FMEP) brands such as the Henson Perimeters and the Macular Pigment Screener (MPS II).

In 2018, Topcon obtained approval from the US Food and Drug Administration (FDA) for the sale of artificial intelligence (AI) based medical device for the detection of an eye disease associated with diabetes called diabetic retinopathy.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy